Nanodevice Tugs Single Proteins to Reveal How Cells Sense Force

Why It Matters

It provides the first tool for structural and interaction studies of proteins under physiological force, opening new avenues for mechanobiology research and force‑targeted therapeutics.

Key Takeaways

• DNA‑based nanodevice exerts precise piconewton forces.
• Demonstrated on talin, confirming vinculin binding under tension.
• Revealed novel talin‑filamin interaction when stretched.
• Design adaptable to linear and potentially non‑linear proteins.
• Opens path to force‑responsive drug targeting.

Pulse Analysis

Mechanotransduction—the process by which cells convert physical cues into biochemical signals—has long been hampered by a lack of methods to observe proteins under realistic tension. Traditional biochemical assays operate in static conditions, while atomic‑force microscopy offers force control but cannot easily capture dynamic protein interactions at the single‑molecule level. The Yale nanodevice bridges this gap by integrating DNA nanotechnology with a mechanical clamp, delivering calibrated forces directly to a protein’s termini and enabling real‑time observation of conformational changes.

The core of the system is a U‑shaped metallic frame equipped with two DNA “handles.” When a trigger induces one handle to fold, the resulting pull stretches the tethered protein inside the cavity. In proof‑of‑concept experiments, the researchers loaded talin, a key linker between integrins and the actin cytoskeleton, and observed the expected recruitment of vinculin under tension, confirming that the applied force mimics physiological conditions. Crucially, the same assay revealed that filamin, another cytoskeletal protein, only binds talin when the latter is stretched—a interaction previously invisible to conventional techniques.

Beyond validating known pathways, the nanodevice promises to transform drug discovery and basic research. By comparing protein structures with and without force, scientists can pinpoint mechanosensitive sites amenable to small‑molecule modulation, potentially leading to therapies that alter cellular responses to stress, such as hypertension or osteoporosis. Future iterations aim to accommodate non‑linear, globular proteins through multi‑arm frames, expanding the toolkit for probing the mechanical dimension of the proteome.